Geiger v. American Tobacco Co.

277 A.D.2d 420, 716 N.Y.S.2d 108, 2000 N.Y. App. Div. LEXIS 12305
CourtAppellate Division of the Supreme Court of the State of New York
DecidedNovember 27, 2000
StatusPublished
Cited by11 cases

This text of 277 A.D.2d 420 (Geiger v. American Tobacco Co.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Geiger v. American Tobacco Co., 277 A.D.2d 420, 716 N.Y.S.2d 108, 2000 N.Y. App. Div. LEXIS 12305 (N.Y. Ct. App. 2000).

Opinion

—In a proposed class action by and on behalf of, among others, New York State residents who have contracted lung and/or throat cancer from smoking cigarettes, to recover damages, inter alia, for failure to warn prior to 1969, the plaintiffs appeal from an order of the Supreme Court, Queens County (Berke, J.), dated September 2, 1999, which denied their cross motion for class certification.

Ordered that the order is affirmed, with costs.

Contrary to the plaintiffs’ contentions, the Supreme Court properly denied their cross motion for class action certification. The purportedly common issues proposed by the plaintiffs in their complaint are actually dependent on the resolution of issues such as addiction and causation as to each individual member of the proposed class. Issues of causation must be resolved on a case-by-case basis, and thus, the difficult questions of causation and the extent of injuries (see, Rosenfeld v Robins Co., 63 AD2d 11, 15-16), weigh against class action treatment (see, Small v Lorillard Tobacco Co., 252 AD2d 1, 7, affd 94 NY2d 43; Rosenfeld v Robins Co., supra, at 17; see also, Insolia v Philip Morris, Inc., 186 FRD 535, 542-543; In re Agent Orange Prod. Liab. Litig., 818 F2d 145, 165).

Although the plaintiffs contend that addiction is not an issue, proof of addiction is essential to the causes of action asserted by the plaintiffs (see, Small v Lorillard Tobacco Co., supra, at 8; Barnes v American Tobacco Co., 161 F3d 127, 144, cert denied 526 US 1114). Addiction is an issue “ ‘[involving] [421]*421far too many subjective factors and present[ing] many of the same manageability concerns * * * to warrant class action treatment’ ” (Small v Lorillard Tobacco Co., supra, at 8; see also, Castano v American Tobacco Co., 84 F3d 734).

With respect to the defective design cause of action, each type and brand of cigarette contains different tar and nicotine yields. Cigarettes are not a generic product. Although each cigarette does contain tar and nicotine, under a strict product liability theory, “ ‘each class member would have to establish that the type of cigarettes he or she smoked contained a defect at the time he or she smoked them’ ” (Barnes v American Tobacco Co., supra, at 145; see also, Arch v American Tobacco Co., 175 FRD 469). Since the plaintiffs allege that the defendants intentionally designed the cigarettes to be addictive by manipulating the levels of tar and nicotine in the cigarettes, proof of whether the defendants caused the injury will depend on addiction as well (see, Barnes v American Tobacco Co., supra, at 145). Additionally, certain defects may be present in some types of cigarettes, while absent in others. Thus, there are issues with respect to that cause of action which affect only individual members of the proposed class.

As the Supreme Court properly concluded, even if there are common issues in this case, those issues do not predominate (see, CPLR 901 [a] [2]). Although a court has the power to sever issues and try the remaining matters as a class action (see, CPLR 906), it does not appear that judicial economy would be served by following that course of conduct in this case (cf., Reynolds Tobacco Co. v Engle, 672 So 2d 39, 41 [Fla]). Bracken, J. P., O’Brien, Santucci and McGinity, JJ., concur.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bardsley v. Great Lakes Indus. Dev., LLC
2022 NY Slip Op 03614 (Appellate Division of the Supreme Court of New York, 2022)
WESTFALL, TAMMY L. v. OLEAN GENERAL HOSPITAL
Appellate Division of the Supreme Court of New York, 2015
Westfall v. Olean General Hospital
132 A.D.3d 1393 (Appellate Division of the Supreme Court of New York, 2015)
Carni v. Continental Home Loans, Inc.
44 Misc. 3d 788 (New York Supreme Court, 2014)
Gomez v. Brill Securities, Inc.
95 A.D.3d 32 (Appellate Division of the Supreme Court of New York, 2012)
Osarczuk v. Associated Universities, Inc.
82 A.D.3d 853 (Appellate Division of the Supreme Court of New York, 2011)
Brown v. R.J. Reynolds Tobacco Co.
576 F. Supp. 2d 1328 (M.D. Florida, 2008)
Liggett Group, Inc. v. Engle
853 So. 2d 434 (District Court of Appeal of Florida, 2003)
Catalano v. Heraeus Kulzer, Inc.
305 A.D.2d 356 (Appellate Division of the Supreme Court of New York, 2003)
Benner v. Becton Dickinson & Co.
214 F.R.D. 157 (S.D. New York, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
277 A.D.2d 420, 716 N.Y.S.2d 108, 2000 N.Y. App. Div. LEXIS 12305, Counsel Stack Legal Research, https://law.counselstack.com/opinion/geiger-v-american-tobacco-co-nyappdiv-2000.